C
CADL
Candel Therapeutics, Inc.
4.960
-0.060-1.20%Opening14:10 04/07 EDT
OPEN/PREV CLOSE5.09/4.950
TODAY RANGE4.895-5.14
VOL826.38K
MARKET CAP362.57M
52 WEEK RANGE4.250-7.25
AVG VOL (3M)1.18M
% TURNOVER1.13%
TURNOVER--
P/E (TTM)-6.8655
% RANGE4.95%
EPS(TTM)-0.7210
P/E(FORWARD)-3.8672
P/B5.23
BVPS0.9458
DIVIDEND--
P/S1,436.36
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP305.30M
SHARES OUTSTANDING73.25M
NEXT EARNINGS05/11-05/15
FREE FLOAT61.68M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·03/18 15:13
Candel Therapeutics Is Maintained at Buy by Citigroup
Dow Jones·03/18 15:13
Candel Therapeutics Price Target Raised to $26.00/Share From $22.00 by Citigroup
Benzinga·03/18 15:03
Citigroup Maintains Buy on Candel Therapeutics, Raises Price Target to $26
TipRanks·03/18 10:22
Candel Therapeutics price target raised to $26 from $22 at Citi
Reuters·03/18 07:36
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks
Seeking Alpha·03/17 18:01
Candel gains on additional mid-stage trial data for lead asset
TipRanks·03/17 12:22
Candel Therapeutics’ aglatimagene shows extended long-term survival in NSCLC
Dow Jones·03/13 20:18
Candel Therapeutics Is Maintained at Buy by Citigroup
Same Industry
Name/Symbol
Change%
Price